189 related articles for article (PubMed ID: 31809607)
21. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
22. Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors.
Shaldam M; Eldehna WM; Nocentini A; Elsayed ZM; Ibrahim TM; Salem R; El-Domany RA; Capasso C; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2021 Apr; 216():113283. PubMed ID: 33667848
[TBL] [Abstract][Full Text] [Related]
23. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
[TBL] [Abstract][Full Text] [Related]
24. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394
[TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
26. Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors.
Elimam DM; Eldehna WM; Salem R; Bonardi A; Nocentini A; Al-Rashood ST; Elaasser MM; Gratteri P; Supuran CT; Allam HA
Eur J Med Chem; 2022 Jan; 228():114008. PubMed ID: 34871842
[TBL] [Abstract][Full Text] [Related]
27. Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity.
Ibrahim HS; Abdelrahman MA; Nocentini A; Bua S; Abdel-Aziz HA; Supuran CT; Abou-Seri SM; Eldehna WM
Bioorg Chem; 2022 Sep; 126():105888. PubMed ID: 35661530
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors.
Al-Wahaibi LH; Youssif BGM; Taher ES; Abdelazeem AH; Abdelhamid AA; Marzouk AA
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443307
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.
Chandra KM; Goud NS; Arifuddin M; Alvala M; Alvala R; Angeli A; Supuran CT
Bioorg Med Chem Lett; 2021 May; 39():127877. PubMed ID: 33640442
[TBL] [Abstract][Full Text] [Related]
30. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors.
Said MA; Eldehna WM; Nocentini A; Bonardi A; Fahim SH; Bua S; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2020 Jan; 185():111843. PubMed ID: 31718943
[TBL] [Abstract][Full Text] [Related]
32. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
Chandak N; Ceruso M; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Sridhar Goud N; Argulwar OS; Soman J; Angeli A; Alvala M; Arifuddin M; Supuran CT
Bioorg Chem; 2020 Nov; 104():104272. PubMed ID: 32961467
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors.
Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT
Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
[TBL] [Abstract][Full Text] [Related]
36. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
37. Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors.
Shaldam M; Nocentini A; Elsayed ZM; Ibrahim TM; Salem R; El-Domany RA; Capasso C; Supuran CT; Eldehna WM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681794
[TBL] [Abstract][Full Text] [Related]
38. Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation.
Elimam DM; Elgazar AA; Bonardi A; Abdelfadil M; Nocentini A; El-Domany RA; Abdel-Aziz HA; Badria FA; Supuran CT; Eldehna WM
Eur J Med Chem; 2021 Dec; 225():113800. PubMed ID: 34482273
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biological evaluation of 3-benzenesulfonamide-linked 3-hydrazinoisatin derivatives as carbonic anhydrase inhibitors.
Swain B; Marde VS; Singh P; Angeli A; Khan A; Yaddanapudi VM; Ullah Q; Supuran CT; Arifuddin M
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300718. PubMed ID: 38466120
[TBL] [Abstract][Full Text] [Related]
40. Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights.
Abdelrahman MA; Eldehna WM; Nocentini A; Bua S; Al-Rashood ST; Hassan GS; Bonardi A; Almehizia AA; Alkahtani HM; Alharbi A; Gratteri P; Supuran CT
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]